H.R. 4837
IntroducedWritten Informed Consent Act
Plain-language analysis
Not yet analyzed.
A plain-language breakdown — including any hidden or off-intent provisions and whether the bill was fast-tracked — is generated separately and reviewed before publishing. It will appear here once ready. Until then, the verbatim text below and the official source are the record.
Full text of the bill
Official source on Congress.gov ↗[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H.R. 4837 Introduced in House (IH)]
<DOC>
119th CONGRESS 1st Session H. R. 4837
To direct the Secretary of Veterans Affairs to expand a directive of the Veterans Health Administration regarding informed consent to apply to certain types of medications.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
August 1, 2025
Mr. Bilirakis (for himself, Mr. Bergman, and Mr. Self) introduced the following bill; which was referred to the Committee on Veterans' Affairs
_______________________________________________________________________
A BILL
To direct the Secretary of Veterans Affairs to expand a directive of the Veterans Health Administration regarding informed consent to apply to certain types of medications.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Written Informed Consent Act''.
SEC. 2. EXPANSION OF CERTAIN DIRECTIVE OF THE VETERANS HEALTH ADMINISTRATION REGARDING INFORMED CONSENT TO APPLY TO CERTAIN TYPES OF MEDICATIONS.
The Secretary of Veterans Affairs shall update VHA Directive 1005 (dated May 13, 2020, and titled ``Informed Consent For Long-term Opioid Therapy For Pain'') to apply to the following types of medications:
(1) Antipsychotics.
(2) Stimulants.
(3) Antidepressants.
(4) Anxiolytics.
(5) Narcotics. <all>